Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06355934
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2024-02-12
Brief Title:
OverTTuRe Characteristics Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Conditions & Keywords Data
Conditions:
| Name |
|---|
| ATTR Amyloidosis |
Keywords:
| Name | View |
|---|---|
| ATTR-CM ATTRv-PN | View |